Down syndrome: trisomy 21
Down syndrome is the best-known chromosomal condition, and it comes from trisomy 21 — three copies of chromosome 21 instead of two, written 47,XX,+21 or 47,XY,+21. Chromosome 21 is the smallest human autosome and carries relatively few genes, which is exactly why an extra copy is compatible with life when extra copies of larger chromosomes are not. The extra dose of those genes shapes development in characteristic ways, including distinctive facial features, low muscle tone in infancy, and a degree of intellectual disability that varies widely from person to person.
Sex-chromosome aneuploidy
The sex chromosomes tolerate aneuploidy far better than autosomes, thanks to a built-in dose-balancing trick. In any cell with more than one X chromosome, all but one are largely switched off through X-inactivation, condensing into a compact Barr body. This keeps the active dose of X genes roughly constant no matter how many X chromosomes are present — which is why sex-chromosome aneuploidies are survivable and often subtle.
Turner syndrome is the only monosomy that is regularly survivable in humans: a single X and no second sex chromosome, written 45,X. Because there is just one X to begin with, the usual buffering is absent, and the condition typically involves short stature and ovarian differences. Klinefelter syndrome runs the other way — an extra X in a male, 47,XXY. The extra X is mostly inactivated, so effects are milder and may include taller stature, reduced fertility, and sometimes learning differences. Many people with XXY are never formally diagnosed.
Quick reference — three syndromes by karyotype:
47,XX,+21 or 47,XY,+21 Down syndrome (trisomy 21, autosomal)
45,X Turner syndrome (monosomy X, female)
47,XXY Klinefelter (extra X, male)
Barr-body count = (number of X chromosomes) - 1
46,XX -> 1 Barr body
45,X -> 0 Barr bodies
47,XXY -> 1 Barr bodyAcross all three, the same theme holds: a change in chromosome number changes the dose of many genes at once, and the body's tolerance depends on which chromosome — and whether dose-balancing like X-inactivation can soften the effect. None of this is a description of any one person's future; outcomes vary enormously, and this guide is reference, not medical advice.